Abstract
Molecular docking is a simulation process where the binding of a small molecule is identified in the structure of a protein target. There are several different computational approaches to solve this problem. Here it is described recent developments in application of evolutionary algorithms to molecular docking simulations. Evolutionary algorithms are classified as a group of computational techniques based on the concepts of Darwins theory of evolution that are designed to find the best possible solution to optimization problems. A successfully implementation of this algorithm can be found in the program MolDock. The main features of MolDock are reviewed here. We also describe application of MolDock to purine nucleoside phosphorylase, shikimate kinase and cyclin-dependent kinase 2.
Keywords: Evolutionary algorithms, molecular docking, structure-based virtual screening, protein-ligand, docking, CDK2, shikimate kinase, PNP
Current Drug Targets
Title: MolDock Applied to Structure-Based Virtual Screening
Volume: 11 Issue: 3
Author(s): Walter Filgueira De Azevedo Jr.
Affiliation:
Keywords: Evolutionary algorithms, molecular docking, structure-based virtual screening, protein-ligand, docking, CDK2, shikimate kinase, PNP
Abstract: Molecular docking is a simulation process where the binding of a small molecule is identified in the structure of a protein target. There are several different computational approaches to solve this problem. Here it is described recent developments in application of evolutionary algorithms to molecular docking simulations. Evolutionary algorithms are classified as a group of computational techniques based on the concepts of Darwins theory of evolution that are designed to find the best possible solution to optimization problems. A successfully implementation of this algorithm can be found in the program MolDock. The main features of MolDock are reviewed here. We also describe application of MolDock to purine nucleoside phosphorylase, shikimate kinase and cyclin-dependent kinase 2.
Export Options
About this article
Cite this article as:
De Azevedo Jr. Filgueira Walter, MolDock Applied to Structure-Based Virtual Screening, Current Drug Targets 2010; 11 (3) . https://dx.doi.org/10.2174/138945010790711941
DOI https://dx.doi.org/10.2174/138945010790711941 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Hypomethylation of Urokinase (uPA) Promoter in Breast and Prostate Cancer: Prognostic and Therapeutic Implications
Current Cancer Drug Targets IAPs, their Antagonists and their Role in Neurological Disease and Cancer
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents The Many Roles of Chemokine Receptors in Neurodegenerative Disorders: Emerging New Therapeutical Strategies
Current Medicinal Chemistry Mining for Protein Kinase Substrates: Integration of Biochemistry, Genetics and Proteomics
Current Proteomics Human Endometrial and Ovarian Cancer Cells: Histone Deacetylase Inhibitors Exhibit Antiproliferative Activity, Potently Induce Cell Cycle Arrest, and Stimulate Apoptosis
Current Medicinal Chemistry LncRNAs as Architects in Cancer Biomarkers with Interface of Epitranscriptomics- Incipient Targets in Cancer Therapy
Current Cancer Drug Targets Targeted Taxane Delivery Systems: Recent Advances
Drug Delivery Letters EGFR-Targeted Therapy in Malignant Glioma: Novel Aspects and Mechanisms of Drug Resistance
Current Molecular Pharmacology Targeted Inhibition of Angiogenic Factors in AIDS-related Disorders
Current Drug Targets - Infectious Disorders Eph/Ephrin Signalling and Function in Oncogenesis: Lessons from Embryonic Development
Current Cancer Drug Targets Protein Degradation Pathways after Brain Ischemia
Current Drug Targets Isolation of a New Sesquiterpene Lactone From Vernonia Zeylanica (L) Less and its Anti-Proliferative Effects in Breast Cancer Cell Lines
Anti-Cancer Agents in Medicinal Chemistry Tumor Escape from Immune Response: Mechanisms and Targets of Activity
Current Drug Targets Alcohol Abuse, Immunosuppression, and Pulmonary Infection
Current Drug Abuse Reviews Recent Patents in Autophagy and Immune Response
Recent Patents on Inflammation & Allergy Drug Discovery An Evolving Role of Piperazine Moieties in Drug Design and Discovery
Mini-Reviews in Medicinal Chemistry Multicolor-FISH Approaches for the Characterization of Human Chromosomes in Clinical Genetics and Tumor Cytogenetics
Current Genomics Locked Nucleic Acid Holds Promise in the Treatment of Cancer
Current Pharmaceutical Design Agonists and Antagonists Acting at P2X7 Receptor
Current Topics in Medicinal Chemistry Role of IL-10 in the Resolution of Airway Inflammation
Current Molecular Medicine